Cargando…
A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
BACKGROUND: The World Health Organization recommends at least 3 annual antibiotic mass drug administrations (MDA) where the prevalence of trachoma is >10% in children ages 1–9 years, with coverage at least at 80%. However, the additional value of higher coverage targeted at children with multiple...
Autores principales: | West, Sheila K., Bailey, Robin, Munoz, Beatriz, Edwards, Tansy, Mkocha, Harran, Gaydos, Charlotte, Lietman, Thomas, Porco, Travis, Mabey, David, Quinn, Thomas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757067/ https://www.ncbi.nlm.nih.gov/pubmed/24009792 http://dx.doi.org/10.1371/journal.pntd.0002415 |
Ejemplares similares
-
Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania
por: West, Sheila K., et al.
Publicado: (2011) -
Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010) -
The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
por: Liu, Fengchen, et al.
Publicado: (2014) -
The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020) -
Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
por: Liu, Fengchen, et al.
Publicado: (2013)